In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas

Antiviral Research

Volumn 48, Issue 2, 2000, Pages 131-142

  Christensen, Neil D ^a,b   Pickel, Martin D ^a   Budgeon, Lynn R ^a   Kreider, John W ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Adefovir; Antiviral testing; Cidofovir; CRPV; Nucleoside analogues; Papillomas; Rabbits

Indexed keywords

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE; 2,6 DIAMINO 9 (2 PHOSPHONOMETHOXYETHYL)PURINE; 9 (2 PHOSPHONYLMETHOXYETHYL)GUANINE; ADEFOVIR; BRYOSTATIN 1; CIDOFOVIR; LOBUCAVIR; NUCLEOSIDE ANALOG; RIBAVIRIN; TENOFOVIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; NONHUMAN; PAPILLOMA; PAPILLOMA VIRUS; PRIORITY JOURNAL; RABBIT; SKIN TOXICITY;

ANIMALS; ANTIVIRAL AGENTS; COTTONTAIL RABBIT PAPILLOMAVIRUS; CYTOSINE; DISEASE MODELS, ANIMAL; HUMANS; NUCLEOSIDES; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; PHOSPHONIC ACIDS; RABBITS; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS;

COTTONTAIL RABBIT PAPILLOMAVIRUS; ORYCTOLAGUS CUNICULUS; PAPILLOMAVIRUS;

EID: 0033645404     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00124-8     Document Type: Article

References (46)

1. Variable light-dose effect on photodynamic therapy for laryngeal papillomas
2. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines
3. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%
4. Therapy of papillomavirus-induced lesions
5. Therapeutic approaches to papillomavirus infections
6. The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas
7. Antibody-mediated neutralization in vivo of infectious papillomaviruses
8. Animal models of papillomavirus infections
9. Interferons in human papillomavirus infections
10. Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and phosphonylmethoxyalkylpyrimiddines
11. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections
12. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients
13. Topical effects of cidofovir on cutaneous rabbit warts: treatment regimen and inoculum dependence
14. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus
15. Interferon and genital warts
16. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals
17. Successful treatment of recalcitrant condyloma with topical cidofovir
18. The Shope papilloma-carcinoma complex of rabbits: A model system of neoplastic progression and spontaneous regression
19. Influence of schedule and mode of administration on effectiveness of podofilox treatment of papillomas
20. Model systems for the treatment of human papillomavirus infections in athymic mice
21. Treatment of latent rabbit and human papillomavirus infections with 9-(2-phosphonylmethoxy)ethylguanine (PMEG)
22. Preclinical system for evaluating topical podofilox treatment of papillomas: dose-response and duration of growth prior to treatment
23. Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal model
24. Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas
25. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections
26. Podofilox-induced regression of Shope papillomas may be independent of host immunity
27. Ribavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus
28. Topical CTC-96 accelerates wart growth in rabbits infected with cottontail rabbit papillomavirus
29. No apparent effect of cidofovir in epidermodysplasia verruciformis
30. Comparison of tar tumors of rabbits and virus-induced tumors
31. Cidofovir. Review of current and potential clinical uses
32. A cottontail rabbit papillomavirus strain (CRPVb) with strikingly divergent E6 and E7 oncoproteins: an insight in the evolution of papillomaviruses
33. Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study
34. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
35. Topical cidofovir is effective in treating extensive penile condylomata acuminata
36. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients
37. Hematoporphyrin derivative therapy of papillomas. Experimental study
38. Histological and molecular analysis of cottontail rabbit papillomavirus-induced papillomas treated with hematoporphyrin derivative photodynamic therapy
39. Infectious papillomatosis of rabbits; With a note on the histopathology
40. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue
41. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]
42. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III)
43. In vitro and animal models for antiviral therapy in papillomavirus infections
44. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
45. Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report
46. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types